Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3749)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$547.25
Total Value
$87.01K
Shares Held After
49,114
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
31
Price
$545.55
Total Value
$16.91K
Shares Held After
49,273
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
576
Price
$545.00
Total Value
$313.92K
Shares Held After
49,304
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
51
Price
$543.61
Total Value
$27.72K
Shares Held After
49,880
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
82
Price
$542.98
Total Value
$44.52K
Shares Held After
49,931
% of Holdings
0.2%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
1,993
Price
$27.06
Total Value
$53.93K
Shares Held After
25,996
% of Holdings
7.1%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
225,191
Price
$0.12
Total Value
$27.70K
Shares Held After
1,838,075
% of Holdings
10.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
686
Price
$72.41
Total Value
$49.67K
Shares Held After
1,176,184
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
92,128
Price
$71.74
Total Value
$6.61M
Shares Held After
1,176,870
% of Holdings
7.3%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
20,208
Price
$71.07
Total Value
$1.44M
Shares Held After
1,268,998
% of Holdings
1.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
85,285
Price
$69.87
Total Value
$5.96M
Shares Held After
1,289,206
% of Holdings
6.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
25,117
Price
$68.91
Total Value
$1.73M
Shares Held After
1,374,491
% of Holdings
1.8%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
17,369
Price
$67.90
Total Value
$1.18M
Shares Held After
1,399,608
% of Holdings
1.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
1,476
Price
$66.40
Total Value
$98.00K
Shares Held After
1,416,977
% of Holdings
0.1%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
2,833,463
Price
$0.01
Total Value
$39.67K
Shares Held After
0
% of Holdings
100.0%
CODEXIS, INC. (CDXS)
De Vre Raymond — Director
Shares
2,605
Price
$2.37
Total Value
$6.17K
Shares Held After
84,811
% of Holdings
3.0%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
17,437
Price
$0.38
Total Value
$6.63K
Shares Held After
361,229
% of Holdings
4.6%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
245,066
Price
$0.38
Total Value
$93.13K
Shares Held After
5,076,685
% of Holdings
4.6%
Axsome Therapeutics, Inc. (AXSM)
JEFFS ROGER — Director
Shares
286
Price
$249.12
Total Value
$71.25K
Shares Held After
58,367
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
548,580
Price
$7.91
Total Value
$4.34M
Shares Held After
16,231,717
% of Holdings
3.4%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
5,000
Price
$6.24
Total Value
$31.20K
Shares Held After
700,000
% of Holdings
0.7%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,674
Price
$16.82
Total Value
$78.62K
Shares Held After
71,365
% of Holdings
6.1%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,200
Price
$231.83
Total Value
$278.20K
Shares Held After
51,549
% of Holdings
2.3%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
1,780
Price
$26.05
Total Value
$46.37K
Shares Held After
27,435
% of Holdings
6.1%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
3,127
Price
$26.03
Total Value
$81.40K
Shares Held After
29,215
% of Holdings
9.7%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
2,645
Price
$26.07
Total Value
$68.96K
Shares Held After
32,342
% of Holdings
7.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$25.00
Total Value
$54.25K
Shares Held After
63,443
% of Holdings
3.3%
LIGAND PHARMACEUTICALS INC (LGND)
Aryeh Jason — Director
Shares
500
Price
$250.00
Total Value
$125.00K
Shares Held After
107,080
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
3,405
Price
$251.62
Total Value
$856.75K
Shares Held After
26,969
% of Holdings
11.2%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
697
Price
$249.53
Total Value
$173.92K
Shares Held After
30,374
% of Holdings
2.2%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
232
Price
$248.11
Total Value
$57.56K
Shares Held After
31,071
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
257
Price
$247.22
Total Value
$63.54K
Shares Held After
31,303
% of Holdings
0.8%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
614
Price
$86.89
Total Value
$53.35K
Shares Held After
1,095,987
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,305
Price
$86.27
Total Value
$198.85K
Shares Held After
1,096,601
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,577
Price
$85.19
Total Value
$134.34K
Shares Held After
1,098,906
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,080
Price
$84.18
Total Value
$90.91K
Shares Held After
1,100,483
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
7,654
Price
$82.78
Total Value
$633.60K
Shares Held After
1,101,563
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
6,770
Price
$82.21
Total Value
$556.56K
Shares Held After
1,109,217
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
17,566
Price
$75.00
Total Value
$1.32M
Shares Held After
73,411
% of Holdings
19.3%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
3,711
Price
$75.00
Total Value
$278.32K
Shares Held After
73,411
% of Holdings
4.8%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
2,159,052
Price
$0.15
Total Value
$330.33K
Shares Held After
2,063,266
% of Holdings
104.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
28,237
Price
$66.30
Total Value
$1.87M
Shares Held After
1,418,453
% of Holdings
2.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
103,301
Price
$65.54
Total Value
$6.77M
Shares Held After
1,446,690
% of Holdings
6.7%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
14,416
Price
$64.48
Total Value
$929.55K
Shares Held After
1,549,991
% of Holdings
0.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
3,051
Price
$0.37
Total Value
$1.13K
Shares Held After
378,666
% of Holdings
0.8%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
42,872
Price
$0.37
Total Value
$15.86K
Shares Held After
5,321,751
% of Holdings
0.8%
Axsome Therapeutics, Inc. (AXSM)
JEFFS ROGER — Director
Shares
286
Price
$246.18
Total Value
$70.41K
Shares Held After
58,653
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
103
Price
$7.00
Total Value
$721.00
Shares Held After
15,683,137
% of Holdings
0.0%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$107.68
Total Value
$969.12K
Shares Held After
7,825
% of Holdings
53.5%
Lyell Immunopharma, Inc. (LYEL)
Shook David — Chief Medical Officer
Shares
1,977
Price
$12.64
Total Value
$24.99K
Shares Held After
20,923
% of Holdings
8.6%
Showing 1001–1050 of 3749 transactions (page 21 of 75)